Skip to main content
. 2024 Feb 6;28:41. doi: 10.1186/s13054-024-04818-1

Table 1.

Baseline characteristics

Overall Thiamine < 8 nmol/L
Variable Total (n = 158) Thiamine (n = 73) Placebo (n = 85) Total (n = 46) Thiamine (n = 19) Placebo (n = 27)
Demographics
Age (median, IQR) 70 (60, 79) 72 (60, 82) 70 (60, 78) 65 (57, 78) 67 (52, 78) 65 (58, 75)
Female, n (%) 73 (46%) 37 (51%) 36 (42%) 24 (52%) 9 (47%) 15 (56%)
Race, n (%)
Black/African American 14 (9%) 6 (8%) 8 (9%) 5 (11%) 2 (11%) 3 (11%)
White 120 (76%) 56 (77%) 64 (75%) 32 (70%) 14 (74%) 18 (67%)
Unknown/other 24 (15%) 11 (15%) 13 (15%) 9 (20%) 3 (16%) 6 (22%)

BMI

(median, IQR)

27.9

(24.2, 34.3)

28.3

(23.8, 34.6)

27.6

(24.7, 34.3)

27.9

(24.8, 34.2)

28.1

(22.1, 32.7)

27.5

(25.2, 36.0)

Past medical history
CAD, n (%) 32 (20%) 14 (19%) 18 (21%) 6 (13%) 3 (16%) 3 (11%)
CHF, n (%) 28 (18%) 11 (15%) 17 (20%) 6 (13%) 1 (5%) 5 (19%)
Dementia, n (%) 10 (6%) 6 (8%) 4 (5%) 5 (11%) 3 (16%) 2 (7%)
Diabetes, n (%) 50 (32%) 27 (37%) 23 (27%) 12 (26%) 6 (32%) 6 (22%)
Pulmonary disease/COPD, n (%) 20 (13%) 11 (15%) 9 (11%) 3 (7%) 1 (5%) 2 (7%)
CKD, n (%) 28 (18%) 14 (19%) 14 (16%) 8 (17%) 4 (21%) 4 (15%)
Laboratory values, interventions, and illness severity

Creatinine

(median, IQR)

1.9

(1.4, 2.7)

1.9

(1.2, 2.5)

2.0

(1.5, 2.7)

1.7

(1.1, 3.0)

1.2

(1.0, 3.0)

1.8

(1.2, 3.0)

Lactate

(median, IQR)

3.4

(2.5, 4.7)

3.1

(2.4, 4.5)

3.4

(2.6, 4.7)

3.2

(2.6, 4.5)

2.9

(2.3, 4.1)

3.4

(2.6, 4.7)

Vasopressor administered 158 (100%) 73 (100%) 85 (100%) 46 (100%) 19 (100%) 27 (100%)

SOFA score

(mean ± SD)

10.6 ± 3.7 10.3 ± 3.6 10.8 ± 3.8 10.2 ± 3.7 10.1 ± 3.4 10.2 ± 4.0

Mechanical

ventilation, n (%)

101 (64%) 49 (67%) 52 (61%) 30 (65%) 14 (74%) 16 (59%)

Definition of abbreviations: BMI = body mass index; CAD = coronary artery disease; CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; CKD = chronic kidney disease; SOFA = sequential organ failure assessment